Avinger Inc Revenue Growth Rates (AVGR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Avinger Inc   (NASDAQ: AVGR)
 

AVGR's Revenue Growth by Quarter and Year

Avinger Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVGR Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September 1.43
2nd Quarter June 1.38
1st Quarter March 1.34
FY 4.15

AVGRs Annual Revenue
Avinger Inc 's Revenue in the fiscal year 2023 $ 7.00 millions
Avinger Inc 's Revenue in the fiscal year 2022 $ 8.27 millions
Avinger Inc 's Revenue in the fiscal year 2021 $ 10.13 millions
Avinger Inc 's Revenue in the fiscal year 2020 $ 8.76 millions
Avinger Inc 's Revenue in the fiscal year 2019 $ 9.13 millions




AVGR Revenue third quarter 2024 Y/Y Growth Comment
Avinger Inc achieved in the third quarter 2024, above Company average Revenue improvement of 2.59% year on year, to $ 1.43 millions.

Looking into third quarter 2024 results within Medical Equipment & Supplies industry 113 other companies have achieved higher Revenue growth. While Avinger Inc ' s Revenue increase of 2.59% ranks overall at the positon no. 1985 in the third quarter 2024.


AVGR Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - -15.5 % -16.67 % -12.09 %
3rd Quarter September 2.59 % -38.22 % -5.06 % 3.04 %
2nd Quarter June -32.35 % -4.23 % -23.93 % 90.48 %
1st Quarter March -29.1 % 0 % -26.17 % 13.27 %
FY   - -15.24 % -18.36 % -

Financial Statements
Avinger Inc 's third quarter 2024 Revenue $ 1.43 millions AVGR's Income Statement
Avinger Inc 's third quarter 2023 Revenue $ 1.39 millions Quarterly AVGR's Income Statement


AVGR Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 21.58 % -11.11 % 1.27 %
3rd Quarter September 3.33 % -31.86 % 5.63 % -15.36 %
2nd Quarter June 2.99 % 7.94 % 12.7 % 9.37 %
1st Quarter March -20.71 % -5.5 % -21.25 % -6.23 %
FY (Year on Year)   - -15.24 % -18.36 % -


Back to AVGR Growth rate Comparisons >> Back to AVGR Growth rate Comparisons >>


Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #361
Overall #1985

Revenue Y/Y Growth Statistics
High Average Low
117.39 % 0.95 % -61.04 %
(Dec 31 2016)   (Mar 31 2018)
Revenue third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #114
Healthcare Sector #361
Overall #1985
Revenue Y/Y Growth Statistics
High Average Low
117.39 % 0.95 % -61.04 %
(Dec 31 2016)   (Mar 31 2018)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Avinger Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
58.87 % 1.08 % -35.16 %
(Mar 31 2016)  


AVGR's III. Quarter Q/Q Revenue Comment
Avinger Inc achieved in the III. Quarter 2024 above company average sequential Revenue growth of 3.33%, to $ 1.43 millions, from $1.38 millions in the second quarter.
AVGR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 64 other companies have achieved higher Revenue quarter on quarter growth. While Avinger Inc 's Revenue growth quarter on quarter, overall rank is 1517.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #65
Healthcare Sector #261
Overall #1517
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #65
Healthcare Sector #261
Overall #1517
Revenue Q/Q Growth Statistics
High Average Low
58.87 % 1.08 % -35.16 %
(Mar 31 2016)  


AVGR's III. Quarter Q/Q Revenue Comment
Avinger Inc achieved in the III. Quarter 2024 above company average sequential Revenue growth of 3.33%, to $ 1.43 millions, from $1.38 millions in the second quarter.
AVGR is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 64 other companies have achieved higher Revenue quarter on quarter growth. While Avinger Inc 's Revenue growth quarter on quarter, overall rank is 1517.


Avinger Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)
Cumulative Revenue 12 Months Ending $ 5.83 $ 5.80 $ 6.46 $ 7.00 $ 7.32
Y / Y Revenue Growth (TTM) -20.29 % -29.17 % -21.94 % -15.35 % -15.64 %
Year on Year Revenue Growth Overall Ranking # 3071 # 1860 # 2098 # 2615 # 3109
Seqeuential Revenue Change (TTM) 0.66 % -10.27 % -7.78 % -4.3 % -10.56 %
Seq. Revenue Growth (TTM) Overall Ranking # 2862 # 1506 # 2347 # 2093 # 2320


Cumulative Revenue growth Comment
Avinger Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2024. If the fiscal year would end in Sep 30 2024, Avinger Inc 's annual Revenue decrease would be -20.29% year on year to $6 millions.

In the Healthcare sector 448 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1860 to 3071.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 449
Overall # 3071

Revenue TTM Y/Y Growth Statistics
High Average Low
79.35 %
 -5.7 %
-54.57 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 423
S&P 500 # 2862
Cumulative Revenue growth Comment
Avinger Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2024. If the fiscal year would end in Sep 30 2024, Avinger Inc 's annual Revenue drop would be -20.29% year on year to $6 millions.

In the Healthcare sector 448 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1860 to 3071.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 139
Healthcare Sector # 449
Overall # 3071

Revenue TTM Y/Y Growth Statistics
High Average Low
79.35 %
-5.7 %
-54.57 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 139
Sector # 423
S&P 500 # 2862




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AVGR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2024
Hologic Inc4.52%$ 4.517 millions
Strata Skin Sciences Inc4.44%$ 4.438 millions
Establishment Labs Holdings Inc 4.38%$ 4.376 millions
Merck and Co Inc 4.35%$ 4.354 millions
Iqvia Holdings Inc 4.28%$ 4.283 millions
Integrated Biopharma Inc4.20%$ 4.200 millions
Catalent Inc 4.18%$ 4.175 millions
Aquestive Therapeutics Inc 4.15%$ 4.153 millions
Organon and Co 4.15%$ 4.147 millions
Healthcare Services Group Inc 4.07%$ 4.074 millions
Zimmer Biomet Holdings Inc 4.03%$ 4.026 millions
Waters Corporation4.02%$ 4.020 millions
Conmed Corporation3.98%$ 3.980 millions
Abbvie Inc 3.83%$ 3.827 millions
Heron Therapeutics Inc 3.61%$ 3.606 millions
Brookdale Senior Living Inc 3.55%$ 3.549 millions
Icad Inc3.54%$ 3.535 millions
Mimedx Group Inc 3.48%$ 3.476 millions
Curis Inc 3.46%$ 3.459 millions
Concentra Group Holdings Parent Inc 3.31%$ 3.307 millions
Agenus Inc3.28%$ 3.282 millions
Nature s Sunshine Products inc 3.19%$ 3.194 millions
Optinose Inc 3.10%$ 3.097 millions
Bionexus Gene Lab Corp 3.00%$ 3.003 millions
Sight Sciences Inc 2.97%$ 2.974 millions
Pacira Biosciences inc 2.83%$ 2.835 millions
Avinger Inc 2.74%$ 2.738 millions
Bio rad Laboratories Inc 2.73%$ 2.726 millions
Ocular Therapeutix Inc 2.28%$ 2.281 millions
Progyny Inc 2.00%$ 2.003 millions


About Avinger Inc Revenue Growth Rates (AVGR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Avinger Inc (CIK 1506928).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-24-033979
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Avinger Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.